Company news

Argent Biopharma Ltd news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Trading halt

August 5, 2020

June Quarterly Activity and Cashflow Report

July 31, 2020

Reinstatement to Official Quotation

July 26, 2020

Suspension from Official Quotation

July 24, 2020

MGC Pharma to acquire 100% of Medicinal Cannabis Clinic

July 19, 2020

MXC Cannabis Research Permit Granted for RMIT Programs

July 13, 2020

MGC Pharma awarded Import Licence by Office of Drug Control

July 7, 2020

COVID-19 Clinical Trial Site Expansion into India

July 2, 2020

MXC Awarded 3-year EU GMP Manufacturing Licence

June 23, 2020

Sale of MGC Nutra to US CBD and Hemp Wellness Company

June 17, 2020

Binding Term Sheet for distribution of CannEpil in Israel

June 14, 2020

3,250 Prescriptions Milestone Surpassed

June 1, 2020

Ethics Committee Approval for CannEpil Phase IIb Trial

May 25, 2020

Binding Term Sheet Signed for Distribution of ArtemiC

May 12, 2020

Voluntary Suspension

May 10, 2020

Phase II Clinical Trial on COVID-19 Patients Commenced

May 5, 2020

March Quarterly Activity and Cashflow Report

April 29, 2020

Second Ethics Committee Approval for Phase II COVID-19 Trial

April 28, 2020

MGC Pharma Secures Commitments for $3.5m Placement

April 27, 2020

Successful Research Results for MGC on Glioblastoma

April 22, 2020

Phase II Clinical Trial on Patients Diagnosed with COVID-19

April 17, 2020

Pause In Trade

April 16, 2020

MGC Pharma Signs Agreement Targeting Anti-Viral Treatments

April 15, 2020

MGC Pharma COVID-19 Business and Operations Update

April 6, 2020

Patients Begin Treatment in Clinical Trial of CogniCann

March 8, 2020

Binding Amendment to Supply Agreement with ONIX Brazil

March 2, 2020

Commercial Supply Deal Signed for First Products into Poland

February 26, 2020

85% Increase in Order Volume of New Prescription Products

February 20, 2020

Security Purchase Plan- Offer Document

February 17, 2020

MGC Pharma announces $1m Strategic Placement and $3m SPP

February 16, 2020

Agreement Signed with Leading Peruvian Distributor

January 27, 2020

Supply Agreement with THC Global for Canndeo Products

January 19, 2020

MGC Pharma Crosses 2,000 Prescription Milestone

January 8, 2020

Launch of New Product Line in Aus & NZ - Mercury Pharma

January 6, 2020

First Shipment of CogniCann en route to Australia

December 18, 2019

Prescriptions Grow Above 1,800 & First Ireland Prescriptions

December 16, 2019

Approval Received for Distribution of CannEpil into Ireland

December 2, 2019

Growth in Prescriptions Issued Continues During November

November 25, 2019

Binding Term Sheet to Immediately Expand into Latin America

November 21, 2019

Pause in Trade

November 20, 2019

MGC Reaches 1,000 Prescription Milestone Ahead of Schedule

October 30, 2019

800 Prescription Milestone Passed for MGC Pharma Products

October 23, 2019

600 Prescription Milestone Passed for MGC Pharma Products

October 15, 2019

MGC Pharma Passes 400 Prescription Milestone in September

October 2, 2019

200 Prescription Milestone Passed in Australia & UK

September 17, 2019

Epilepsy Clinical Study Comparing CannEpil to 100% CBD

September 2, 2019

Placement Settlement Complete, Info on the Priority Offer

August 29, 2019

Appendix 4E and Audited 2019 Financial Report

August 28, 2019

Approval Granted for Large-Scale Research Project with IHPS

August 26, 2019

Trial on the Effect of CannEpil on Driver Competency

August 23, 2019

← Newer news releases · Older news releases →

Decks

The 5 newest of 10 decks. Every deck is listed under its year.